Skip to Main Content

Paper Details

Real-world experience of patients with multiple myeloma receiving ide-cel after a prior BCMA-targeted therapy.
Blood Cancer J
12
2023
Author NameAffiliation
Lauren C PeresH. Lee Moffitt Cancer Center and Research Institute
  • 1 - 1

Datasets

Release 1.2